WEBINAR | Health AI Policy in 2026: Navigating the Federal-State Divide

Randi Seigel, Partner and Jared Augenstein, Senior Managing Director, Manatt Health. Health AI policy has reached an inflection point in 2026. States have introduced more than 240 bills in the first quarter alone, focused on guardrails around AI chatbots, clinical oversight and patient consent, payor use of AI in utilization management and downcoding, liability, and transparency. The federal government is moving in the opposite direction, with the White House, Congress, and agencies advancing a deregulatory, pro-adoption posture and actively pressuring states to stand down. For health tech leaders, this divergence creates both opportunity and risk: AI sandboxes and regulatory relief programs in states like Utah and Texas are opening new pathways to market, while federal initiatives including CMMI’s ACCESS Model, FDA’s TEMPO Pilot, ARPA-H’s ADVOCATE program, and CMS’s new Digital Health Tech Ecosystem are reshaping reimbursement, regulatory pathways, and commercial strategy. Join Randi Seigel and Jared Augenstein of Manatt Health for a practical session that cuts through the noise, surfaces the state and federal actions most likely to affect your product, go-to-market, and compliance decisions, and highlights what to watch through the rest of 2026.